chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: VARZOS
Symptoms: Chills, Injection site pain, Ophthalmic herpes zoster, Pyrexia
Clinical narrative: shingles in eye; arm pain at injection site; fever; chills; This case was reported by a consumer and described the occurrence of ophthalmic herpes zoster in a 64-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included ophthalmic herpes zoster (had shingles in eyes, especially the right eye, numerous times years ago). Previously administered products included Shingles vaccine with an associated reaction of no adverse event (received the original Shingles vaccines a few years ago and did not experience any side effects, did not get shingles again). Concomitant products included metoprolol succinate and lovastatin.   On 15th June 2022, the patient received the 1st dose of Shingrix. On 15th June 2022, less than a day after receiving Shingrix, the patient experienced injection site pain, fever and chills. On an unknown date, the patient experienced ophthalmic herpes zoster (serious criteria GSK medically significant). On an unknown date, the outcome of the ophthalmic herpes zoster, injection site pain, fever and chills were recovered/resolved.   It was unknown if the reporter considered the ophthalmic herpes zoster, injection site pain, fever and chills to be related to Shingrix.     Linked case(s) involving the same patient:  US2023AMR009326   Additional Information: GSK Receipt Date: 20-JAN-2023 Reporter's Comments: The case was self reported by the patient. The patient received first dose of Shingrix at her physician's office and experienced arm pain at the injection site and fever and chills the night she received the vaccine. The patient also had shingles in right eye for several days but it cleared up on its own. The patient had now spent over one thousand dollars out of pocket for doctor visits, prescription, lab work, and treatments. The patient had been to an urgent care clinic run by her primary care physician practice, had been to the eye doctor at least 5 times, and her PCP once.  The patient now being treated by a cornea specialist who did a procedure on her eye and she had to go back to next week. All of the health care providers the patient had seen said that none of the literature on the vaccine lists this as a possible reaction. The symptoms was treated. The reporter did not consent to follow up. Additional Supportive Information: For tolerance of 2nd dose, refer case US2023AMR009326.; Sender's Comments:  US-GSK-US2023AMR009326:same reporter - 2nd dose
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Wrong product administered
Clinical narrative: patient that she had received the Moderna Bivalent Dose as the first Primary Series vaccine.; No adverse event; This spontaneous case was reported by a consumer and describes the occurrence of WRONG PRODUCT ADMINISTERED (patient that she had received the Moderna Bivalent Dose as the first Primary Series vaccine.) and NO ADVERSE EVENT (No adverse event) in an adult female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. ASKU) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced WRONG PRODUCT ADMINISTERED (patient that she had received the Moderna Bivalent Dose as the first Primary Series vaccine.) and NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (patient that she had received the Moderna Bivalent Dose as the first Primary Series vaccine.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        The action taken with mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) was unknown.   For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (patient that she had received the Moderna Bivalent Dose as the first Primary Series vaccine.).    No concomitant medication information was reported.  It was reported that Limited Adverse Event reported The caller is a representative for a county.The caller wanted to find out if a lot number of Moderna Covid-19 vaccine is Monovalent or Bivalent.Agent offered to escalate his case. Caller declined the escalation and the caller said that he has another way to check what vaccine that the patient received Monovalent or Bivalent. The caller did say that when the patient went back to the Pharmacy where she received her first Moderna Covid-19 vaccine to receive her second Primary Series Moderna vaccine dose that the Pharmacy would not give her the second dose because they told the patient that she had received the Moderna Bivalent Dose as the first Primary Series vaccine. It is still not clear if the caller received monovalent or bivalent vaccine for her first Primary Series dose.   No treatment medication information was reported.
Sex: F
Vaccine: HPV4
Symptoms: Postural orthostatic tachycardia syndrome
Clinical narrative: POTS; Information has been received from a lawyer referring to a 16-year-old female patient regarding a case in litigation. Information about concurrent condition, medical history and concomitant medication was not reported. On an unknown date, the patient was vaccinated with Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL) (strength, dose, lot# and route unknown) for prophylaxis. On an unknown date, the patient experienced postural orthostatic tachycardia syndrome (POTS). Reported date of injury was unspecified date in 2006. The outcome of the event was not reported. The causality assessment was considered as related by the lawyer.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2301USA006946:
Sex: F
Vaccine: HPV4
Symptoms: Dizziness, Fatigue, Headache, Postural orthostatic tachycardia syndrome, Syncope
Clinical narrative: syncope; POTS; headache; dizziness; fatigue; Information has been received from a lawyer referring to a 21-year-old female patient regarding a case in litigation. Information about concurrent condition, medical history and concomitant medication was not reported. On an unknown date, the patient was vaccinated with Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL) (strength, dose, lot# and route unknown) for prophylaxis. On an unknown date, the patient experienced postural orthostatic tachycardia syndrome (POTS), headache, dizziness, fatigue, and syncope. Reported date of injury was unspecified date in 2006. The outcome of the events was not reported. The causality assessment was considered as related by the lawyer.  Upon internal review, syncope was determined to be medically significant.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2301USA006946:
Sex: F
Vaccine: HPV4
Symptoms: Autoimmune disorder, Death, Dizziness, Headache, Postural orthostatic tachycardia syndrome
Clinical narrative: seizure; death; autoimmune disorder; lupus/autoimmune disorder; POTS; dizziness; headaches; Information has been received from a lawyer referring to a female patient of unknown age regarding a case in litigation. Information about concurrent condition, medical history and concomitant medication was not reported. On an unknown date, the patient was vaccinated with Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL) (strength, dose, lot# and route unknown) for prophylaxis. On an unknown date, the patient experienced postural orthostatic tachycardia syndrome (POTS), seizures, lupus, autoimmune disorder, headache and dizziness. On an unknown date, the patient died. Cause of death was not reported. It was unknown if an autopsy was performed. Reported date of injury was unspecified date in 2007. The outcome of the events was not reported. The causality assessment was considered as related by the lawyer.  Upon internal review, seizures, autoimmune disorder and lupus was determined to be medically significant.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2301USA006946:
Sex: F
Vaccine: HPV4
Symptoms: Seizure, Systemic lupus erythematosus
Clinical narrative: seizure; death; autoimmune disorder; lupus/autoimmune disorder; POTS; dizziness; headaches; Information has been received from a lawyer referring to a female patient of unknown age regarding a case in litigation. Information about concurrent condition, medical history and concomitant medication was not reported. On an unknown date, the patient was vaccinated with Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL) (strength, dose, lot# and route unknown) for prophylaxis. On an unknown date, the patient experienced postural orthostatic tachycardia syndrome (POTS), seizures, lupus, autoimmune disorder, headache and dizziness. On an unknown date, the patient died. Cause of death was not reported. It was unknown if an autopsy was performed. Reported date of injury was unspecified date in 2007. The outcome of the events was not reported. The causality assessment was considered as related by the lawyer.  Upon internal review, seizures, autoimmune disorder and lupus was determined to be medically significant.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2301USA006946:
Sex: F
Vaccine: HPV4
Symptoms: Postural orthostatic tachycardia syndrome
Clinical narrative: POTS; dizziness; Information has been received from a lawyer referring to a female patient of unknown age regarding a case in litigation. Information about concurrent condition, medical history and concomitant medication was not reported. On an unknown date, the patient was vaccinated with Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL) (strength, dose, lot# and route unknown) for prophylaxis. On an unknown date, the patient experienced postural orthostatic tachycardia syndrome (POTS) and dizziness. Reported date of injury was unspecified date in 2008. The outcome of the event was not reported. The causality assessment was considered as related by the lawyer.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2301USA006946:
Sex: F
Vaccine: HPV4
Symptoms: Epilepsy, Focal dyscognitive seizures, Headache, Postural orthostatic tachycardia syndrome
Clinical narrative: epilepsy with complex focal seizure; POTS/headache; headache; Information has been received from a lawyer referring to a 15-year-old female patient regarding a case in litigation. Information about concurrent condition, medical history and concomitant medication was not reported. On an unknown date, the patient was vaccinated with Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL) (strength, dose, lot# and route unknown) for prophylaxis. On an unknown date, the patient experienced postural orthostatic tachycardia syndrome (POTS), headache and epilepsy with complex focal seizure. Reported date of injury was unspecified date in 2009. The outcome of the events was not reported. The causality assessment was considered as related by the lawyer.  Upon internal review, epilepsy with complex focal seizure was determined to be medically significant.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2301USA006946:
Sex: F
Vaccine: COVID19
Symptoms: Off label use
Clinical narrative: 0.5 ML DOSE GIVEN AS 2 TIMES OF 0.25 ML DOSES AT THE SAME VISIT (OFF LABEL DOSING FREQUENCY); This spontaneous report received from a patient concerned a female of unspecified age, race and ethnicity. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: The patient been covid free. The patient had previously received initial dose of covid-19 vaccine ad26.cov2.s (dose number in series 1) (suspension for injection, route of admin not reported, batch number: 204A21A and expiry: Unknown) 0.5 ml, 1 total, dose 1 administered on 28-APR-2021 for covid-19 prophylaxis. It was unknown whether patient had any adverse events following vaccination with initial dose of covid-19 vaccine ad26.cov2.s (dose number in series 1). The patient received booster dose of covid-19 vaccine ad26.cov2.s (dose number in series 2) (suspension for injection, route of admin not reported, batch number: 1821286 and expiry: Unknown) 1 total, dose 2 administered on 29-OCT-2021, 0.5 ml dose given as 2 times of 0.25 ml doses at the same visit for covid-19 prophylaxis which was off label dosing frequency associated with off label use (dose number in series 2). No concomitant medications were reported. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of 0.5 ml dose given as 2 times of 0.25 ml doses at the same visit (off label dosing frequency) was not reported. This report was non-serious. This case, involving the same patient is linked to 20230138182. This case, from the same reporter is linked to 20230138443.
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: WAS GIVEN EXPIRED VACCINE/PRODUCTS HAD REACHED THEIR LISTED EXPIRATION DATES; This spontaneous report received from a health care professional concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808986 expiry: 01-MAR-2022) dose was not reported, administered on 08-APR-2022 for covid-19 prophylaxis. The drug was associated with Drug taken beyond expiry date. No concomitant medications were reported. On 08-APR-2022, the patient experienced was given expired vaccine/products had reached their listed expiration dates. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of was given expired vaccine/products had reached their listed expiration dates was not reported. This report was non-serious. This case, from the same reporter is linked to 20230150157, 20230150255, 20230150340 and 20230150423.
Age: 71.0
Sex: F
Vaccine: COVID19, COVID19, COVID19-2
Symptoms: Unevaluable event
Clinical narrative: patient hospitalized
Age: 15.0
Sex: F
Vaccine: COVID19-2
Symptoms: Chills, Headache, Nausea, Pyrexia
Clinical narrative: My 15 yr old child received the bivalent Covid booster by Pfizer around 6:30 pm yesterday. Overnight developed chills, fever (101), headache, nausea.
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Blindness unilateral, Cardiac disorder, Infertility, Pain
Clinical narrative: Since taking my second Pfizer vaccine, I have had several heart issues, loss of sight in one eye, burning pains which make my feet/hands like they are on fire, and now I've been told I'm infertile. I had NONE of these issues prior to YOUR vaccine.
Age: 45.0
Sex: F
Vaccine: RAB
Symptoms: Product administered at inappropriate site
Clinical narrative: Presented to hospital in ED, per the advice of the on call nurse department of health after scratch on right leg and right and right thumb from a sick appearing cat which died on day 10 post scratch. The cat died naturally just prior to being euthanized at the vet. I asked for the PEP. I was given two injections of HRIG on the right gluteal area, and one injection of HRIG on the left. Ok, that's acceptable. I was given the rabies vaccine in the left gluteal area, which I learned later is not acceptable. I was also advised that the rabies vaccine and the HRIG should be injected into anatomically different body parts to be effective. My mother is a retired public health nurse and informed me of this the next day after learning of my experience. I googled this topic, and it was immediately apparent that I shouldn't have gotten the vaccine in the gluteal and I shouldn't have gotten GRIG and the vaccine in the same body part. I called back to the facility and explained I didn't think the dose was valid and an error was made. I was told to download my chart app and send a portal message to the provider who was not currently working. I explained this was time sensitive and regarding a post exposure to a fatal disease and was told "well he wouldn't have put it there for no reason." Actually, a nurse did the injection, but I had to return to the ED at the main hospital location and was advised to wait until my day 3 injection. I don't think that was correct either, as my limited research indicated I should've started over because the first was not valid due to location and proximity to the HRIG. Thankfully, the cat was negative for rabies, but that was a long four days.
Age: 5.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: Pt received incorrect dose of Covid Vaccine. Pt received for age group 6- 11 years instead of the 6 months to 5 years dose.  Provider notified and felt medically that pt is stable and explained situation to father at the time of differnace and signs and symptoms to be aware of.   Mother contacted 1/25 to check on pt and stated he was doing well and denied any adverse reactions.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Chills, Fatigue, Pain
Clinical narrative: Started as severe chills at bedtime same day as vaccination. The next day was body aches, fatigue and chills again at night. I have had all these symptoms in varying degrees every day since I was vaccinated. On some days the fatigue and body aches can be so severe as to be debillatating.
Age: 63.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered, Underdose
Clinical narrative: Patient was vaccinated with COVID booster and under-dosed.
Age: 62.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Patient reported redness and sweeling at the injection site reaction folloing her vaccination.
Age: 73.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough Case
Age: 68.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Nasal congestion, Pain, Pyrexia, Respiratory tract congestion
Clinical narrative: On 01/18/2023 , I started having nasal and chest congestion, post nasal drip and body aches. On 01/19/2023, I had a fever and severe body aches. I reached out to my physician and was prescribed a course of PAXLOVID.
Age: 68.0
Sex: F
Vaccine: COVID19-2
Symptoms: SARS-CoV-2 test positive, Upper-airway cough syndrome
Clinical narrative: On 01/18/2023 , I started having nasal and chest congestion, post nasal drip and body aches. On 01/19/2023, I had a fever and severe body aches. I reached out to my physician and was prescribed a course of PAXLOVID.
Age: 52.0
Sex: F
Vaccine: FLUA4
Symptoms: No adverse event, Product storage error
Clinical narrative: no adverse event, recommended redosing as fridge temp was out of range
Age: 56.0
Sex: F
Vaccine: COVID19-2
Symptoms: Anxiety, Electrocardiogram, Feeling abnormal, Feeling jittery, Full blood count
Clinical narrative: Developed increasing palpitations, jittery sensation, and increasing anxiety. Feels like "I'm withdrawing from something"
Age: 56.0
Sex: F
Vaccine: COVID19-2
Symptoms: Metabolic function test, Palpitations, Troponin
Clinical narrative: Developed increasing palpitations, jittery sensation, and increasing anxiety. Feels like "I'm withdrawing from something"
Age: 47.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Anion gap increased, Anxiety, Blood bicarbonate decreased, Blood glucose increased, COVID-19
Clinical narrative: Patient with history of COVID vaccines who admitted to hospital after COVID detected PCR prior to admit.  Provider d/c note:  "48 YO male with PMH Bipolar disorder, DM2, HTN,  who presents to the hospital with complaint of SOB due to anxiety. Labs with elevated anion gap, elevated blood glucose (200s) and low bicarb. Suspected starvation ketosis vs DKA, patient started on insulin gtt and BMP q4H. With D5 NS Kcl infusion initially. As anion gap closed and bicarb improved, patient switched over to lantus and lispro (titrated to lantus 30 units daily and lispro 10 units three times daily). As patient was taking humalin u500 at home, he was on a carb counting dose; however, suspect that current starvation ketosis likely from use on short acting insulin alone without any long acting coverage. Patient has known gastric lesion which GI was consulted on previous admission, but he has not followed up with recommendation to follow up at gastroenterology. He has severe anxiety and mood disorder that limits his functioning. Psychiatry was consulted during this admission and medications were uptitrated (including vraylar 6mg daily, zoloft 100 mg daily and prn olanzapine for anxiety). Currently, stable for discharge. "
Age: 47.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Condition aggravated, Diabetic ketoacidosis, Dyspnoea, Insulin therapy, Laboratory test abnormal
Clinical narrative: Patient with history of COVID vaccines who admitted to hospital after COVID detected PCR prior to admit.  Provider d/c note:  "48 YO male with PMH Bipolar disorder, DM2, HTN,  who presents to the hospital with complaint of SOB due to anxiety. Labs with elevated anion gap, elevated blood glucose (200s) and low bicarb. Suspected starvation ketosis vs DKA, patient started on insulin gtt and BMP q4H. With D5 NS Kcl infusion initially. As anion gap closed and bicarb improved, patient switched over to lantus and lispro (titrated to lantus 30 units daily and lispro 10 units three times daily). As patient was taking humalin u500 at home, he was on a carb counting dose; however, suspect that current starvation ketosis likely from use on short acting insulin alone without any long acting coverage. Patient has known gastric lesion which GI was consulted on previous admission, but he has not followed up with recommendation to follow up at gastroenterology. He has severe anxiety and mood disorder that limits his functioning. Psychiatry was consulted during this admission and medications were uptitrated (including vraylar 6mg daily, zoloft 100 mg daily and prn olanzapine for anxiety). Currently, stable for discharge. "
Age: 47.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: SARS-CoV-2 test positive, Starvation ketoacidosis
Clinical narrative: Patient with history of COVID vaccines who admitted to hospital after COVID detected PCR prior to admit.  Provider d/c note:  "48 YO male with PMH Bipolar disorder, DM2, HTN,  who presents to the hospital with complaint of SOB due to anxiety. Labs with elevated anion gap, elevated blood glucose (200s) and low bicarb. Suspected starvation ketosis vs DKA, patient started on insulin gtt and BMP q4H. With D5 NS Kcl infusion initially. As anion gap closed and bicarb improved, patient switched over to lantus and lispro (titrated to lantus 30 units daily and lispro 10 units three times daily). As patient was taking humalin u500 at home, he was on a carb counting dose; however, suspect that current starvation ketosis likely from use on short acting insulin alone without any long acting coverage. Patient has known gastric lesion which GI was consulted on previous admission, but he has not followed up with recommendation to follow up at gastroenterology. He has severe anxiety and mood disorder that limits his functioning. Psychiatry was consulted during this admission and medications were uptitrated (including vraylar 6mg daily, zoloft 100 mg daily and prn olanzapine for anxiety). Currently, stable for discharge. "
Age: 0.33
Sex: M
Vaccine: UNK
Symptoms: Autopsy, Infant irritability, Respiration abnormal, Sudden infant death syndrome, Viral test
Clinical narrative: Sudden infant death several days after receiving 4 month vaccine series Became fussy and developed raspy breathing in the days following the vaccine administration
Age: 42.0
Sex: M
Vaccine: COVID19-2, FLU4, PNC20, TDAP
Symptoms: Incorrect product formulation administered, Underdose
Clinical narrative: Patient was vaccinated with COVID booster and under-dosed.
Age: 16.0
Sex: M
Vaccine: MNQ
Symptoms: Alcohol test negative, Blood albumin increased, Computerised tomogram head normal, Drug screen positive, Full blood count abnormal
Clinical narrative: Patient a a tonic-clonic seizure about 2-4 hours after administration of the vaccine.  He was evaluated in the ER and discharge.  At this time no subsequent seizures.
Age: 16.0
Sex: M
Vaccine: MNQ
Symptoms: Generalised tonic-clonic seizure, Lymphoblast count increased, Metabolic function test, Protein urine present, Urine analysis
Clinical narrative: Patient a a tonic-clonic seizure about 2-4 hours after administration of the vaccine.  He was evaluated in the ER and discharge.  At this time no subsequent seizures.
Age: 16.0
Sex: M
Vaccine: MNQ
Symptoms: Urine cannabinoids increased, Urine ketone body present, White blood cell count increased
Clinical narrative: Patient a a tonic-clonic seizure about 2-4 hours after administration of the vaccine.  He was evaluated in the ER and discharge.  At this time no subsequent seizures.
Age: 69.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, Cough, Fatigue, Pain, Productive cough
Clinical narrative: Got Covid 12/29/2022 fatigue body aches lasted for 3 weeks. Experienced a lot of phlegm and deep coughing.
Age: 69.0
Sex: M
Vaccine: COVID19-2
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Got Covid 12/29/2022 fatigue body aches lasted for 3 weeks. Experienced a lot of phlegm and deep coughing.
Age: 18.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Atrioventricular block complete, Cardiac pacemaker insertion, Intensive care, Laboratory test
Clinical narrative: None at the time.  7 Months after 2nd vaccine shot, hospitalized in ICU for complete heart block.  No previous heart or any other medical issues.  Ended up with a permanent pacemaker.
Age: 95.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough Case
Age: 24.0
Sex: F
Vaccine: HEP
Symptoms: Underdose
Clinical narrative: Patient was injected with the (0.5ml) incorrect volume and should of been injected 1ml.  Patient returned to receive the other 0.5ml the same day.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Acute myocardial infarction, Acute respiratory failure, Angiogram pulmonary abnormal, Atrial fibrillation, Biliary obstruction
Clinical narrative: Came to ED with 11/11/2022 Chief Complaint of SOB.  Initial treatment with: Decadron for hypoxia in the setting of COVID infection, ceftriaxone and azithromycin for pneumonia,  IV fluids and insulin. Hospitalized in ICU 11/11/2022 with acute hypoxic respiratory failure, diabetic ketoacidosis, sepsis. Evaluation revealed covid pneumonia, influenza B and superimposed community-acquired pneumonia, bilateral. She required mechanical ventilation on 11/12/2022. Her hospital course was complicated by Non ST elevated myocardial infarction, right perforator pontine stroke and atrial fibrillation with rapid ventricular response. Ultimately, decision was made to extubate 11/21/2022 and transition to hospice 11/22/2022  Patient expired 11/22/2022 @1803. Submitter does not have access to full medical record. If further information is needed, please contact Memorial Hospital  or HOSPICE.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose increased, Blood lactic acid, COVID-19, COVID-19 pneumonia, Cerebrovascular accident
Clinical narrative: Came to ED with 11/11/2022 Chief Complaint of SOB.  Initial treatment with: Decadron for hypoxia in the setting of COVID infection, ceftriaxone and azithromycin for pneumonia,  IV fluids and insulin. Hospitalized in ICU 11/11/2022 with acute hypoxic respiratory failure, diabetic ketoacidosis, sepsis. Evaluation revealed covid pneumonia, influenza B and superimposed community-acquired pneumonia, bilateral. She required mechanical ventilation on 11/12/2022. Her hospital course was complicated by Non ST elevated myocardial infarction, right perforator pontine stroke and atrial fibrillation with rapid ventricular response. Ultimately, decision was made to extubate 11/21/2022 and transition to hospice 11/22/2022  Patient expired 11/22/2022 @1803. Submitter does not have access to full medical record. If further information is needed, please contact Memorial Hospital  or HOSPICE.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Chest X-ray abnormal, Cholangitis, Computerised tomogram abdomen abnormal, Death, Diabetic ketoacidosis
Clinical narrative: Came to ED with 11/11/2022 Chief Complaint of SOB.  Initial treatment with: Decadron for hypoxia in the setting of COVID infection, ceftriaxone and azithromycin for pneumonia,  IV fluids and insulin. Hospitalized in ICU 11/11/2022 with acute hypoxic respiratory failure, diabetic ketoacidosis, sepsis. Evaluation revealed covid pneumonia, influenza B and superimposed community-acquired pneumonia, bilateral. She required mechanical ventilation on 11/12/2022. Her hospital course was complicated by Non ST elevated myocardial infarction, right perforator pontine stroke and atrial fibrillation with rapid ventricular response. Ultimately, decision was made to extubate 11/21/2022 and transition to hospice 11/22/2022  Patient expired 11/22/2022 @1803. Submitter does not have access to full medical record. If further information is needed, please contact Memorial Hospital  or HOSPICE.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Electrocardiogram ST-T change, Endotracheal intubation, Fibrin D dimer increased, Hilar lymphadenopathy
Clinical narrative: Came to ED with 11/11/2022 Chief Complaint of SOB.  Initial treatment with: Decadron for hypoxia in the setting of COVID infection, ceftriaxone and azithromycin for pneumonia,  IV fluids and insulin. Hospitalized in ICU 11/11/2022 with acute hypoxic respiratory failure, diabetic ketoacidosis, sepsis. Evaluation revealed covid pneumonia, influenza B and superimposed community-acquired pneumonia, bilateral. She required mechanical ventilation on 11/12/2022. Her hospital course was complicated by Non ST elevated myocardial infarction, right perforator pontine stroke and atrial fibrillation with rapid ventricular response. Ultimately, decision was made to extubate 11/21/2022 and transition to hospice 11/22/2022  Patient expired 11/22/2022 @1803. Submitter does not have access to full medical record. If further information is needed, please contact Memorial Hospital  or HOSPICE.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Hyperglycaemia, Hypoxia, Influenza, Influenza B virus test positive, Intensive care
Clinical narrative: Came to ED with 11/11/2022 Chief Complaint of SOB.  Initial treatment with: Decadron for hypoxia in the setting of COVID infection, ceftriaxone and azithromycin for pneumonia,  IV fluids and insulin. Hospitalized in ICU 11/11/2022 with acute hypoxic respiratory failure, diabetic ketoacidosis, sepsis. Evaluation revealed covid pneumonia, influenza B and superimposed community-acquired pneumonia, bilateral. She required mechanical ventilation on 11/12/2022. Her hospital course was complicated by Non ST elevated myocardial infarction, right perforator pontine stroke and atrial fibrillation with rapid ventricular response. Ultimately, decision was made to extubate 11/21/2022 and transition to hospice 11/22/2022  Patient expired 11/22/2022 @1803. Submitter does not have access to full medical record. If further information is needed, please contact Memorial Hospital  or HOSPICE.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Leukocytosis, Lung consolidation, Lung disorder, Lung infiltration, Lung opacity
Clinical narrative: Came to ED with 11/11/2022 Chief Complaint of SOB.  Initial treatment with: Decadron for hypoxia in the setting of COVID infection, ceftriaxone and azithromycin for pneumonia,  IV fluids and insulin. Hospitalized in ICU 11/11/2022 with acute hypoxic respiratory failure, diabetic ketoacidosis, sepsis. Evaluation revealed covid pneumonia, influenza B and superimposed community-acquired pneumonia, bilateral. She required mechanical ventilation on 11/12/2022. Her hospital course was complicated by Non ST elevated myocardial infarction, right perforator pontine stroke and atrial fibrillation with rapid ventricular response. Ultimately, decision was made to extubate 11/21/2022 and transition to hospice 11/22/2022  Patient expired 11/22/2022 @1803. Submitter does not have access to full medical record. If further information is needed, please contact Memorial Hospital  or HOSPICE.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy mediastinal, Mechanical ventilation, Metabolic acidosis, PO2 decreased, Platelet count increased
Clinical narrative: Came to ED with 11/11/2022 Chief Complaint of SOB.  Initial treatment with: Decadron for hypoxia in the setting of COVID infection, ceftriaxone and azithromycin for pneumonia,  IV fluids and insulin. Hospitalized in ICU 11/11/2022 with acute hypoxic respiratory failure, diabetic ketoacidosis, sepsis. Evaluation revealed covid pneumonia, influenza B and superimposed community-acquired pneumonia, bilateral. She required mechanical ventilation on 11/12/2022. Her hospital course was complicated by Non ST elevated myocardial infarction, right perforator pontine stroke and atrial fibrillation with rapid ventricular response. Ultimately, decision was made to extubate 11/21/2022 and transition to hospice 11/22/2022  Patient expired 11/22/2022 @1803. Submitter does not have access to full medical record. If further information is needed, please contact Memorial Hospital  or HOSPICE.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Pleural effusion, Pneumonia, Pulmonary fibrosis, Pulmonary mass, SARS-CoV-2 test positive
Clinical narrative: Came to ED with 11/11/2022 Chief Complaint of SOB.  Initial treatment with: Decadron for hypoxia in the setting of COVID infection, ceftriaxone and azithromycin for pneumonia,  IV fluids and insulin. Hospitalized in ICU 11/11/2022 with acute hypoxic respiratory failure, diabetic ketoacidosis, sepsis. Evaluation revealed covid pneumonia, influenza B and superimposed community-acquired pneumonia, bilateral. She required mechanical ventilation on 11/12/2022. Her hospital course was complicated by Non ST elevated myocardial infarction, right perforator pontine stroke and atrial fibrillation with rapid ventricular response. Ultimately, decision was made to extubate 11/21/2022 and transition to hospice 11/22/2022  Patient expired 11/22/2022 @1803. Submitter does not have access to full medical record. If further information is needed, please contact Memorial Hospital  or HOSPICE.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Sepsis, Sinus tachycardia, Superinfection, White blood cell count increased
Clinical narrative: Came to ED with 11/11/2022 Chief Complaint of SOB.  Initial treatment with: Decadron for hypoxia in the setting of COVID infection, ceftriaxone and azithromycin for pneumonia,  IV fluids and insulin. Hospitalized in ICU 11/11/2022 with acute hypoxic respiratory failure, diabetic ketoacidosis, sepsis. Evaluation revealed covid pneumonia, influenza B and superimposed community-acquired pneumonia, bilateral. She required mechanical ventilation on 11/12/2022. Her hospital course was complicated by Non ST elevated myocardial infarction, right perforator pontine stroke and atrial fibrillation with rapid ventricular response. Ultimately, decision was made to extubate 11/21/2022 and transition to hospice 11/22/2022  Patient expired 11/22/2022 @1803. Submitter does not have access to full medical record. If further information is needed, please contact Memorial Hospital  or HOSPICE.
Age: 63.0
Sex: F
Vaccine: YF
Symptoms: Amnesia, Blood glucose normal, Injection site erythema, Injection site pain, Transient global amnesia
Clinical narrative: Client reported short-term memory loss the afternoon of 1/16/23 while conversing with family. She does not remember the incident, states family members told her she was repeating questions over and over after being answered. They checked her blood glucose as a diabetic which was WNL, and they took her to an ED. Diagnosis of TGA and elevated troponin. Amnesia resolved around midnight same day, but was inpatient x2d for troponin levels. Client reports no other symptoms other than redness and soreness at injection site prior to amnesia onset. Client was discharged from hospital after resolution of high troponin, no DC medications or plan for follow-up visits.
Age: 63.0
Sex: F
Vaccine: YF
Symptoms: Troponin increased
Clinical narrative: Client reported short-term memory loss the afternoon of 1/16/23 while conversing with family. She does not remember the incident, states family members told her she was repeating questions over and over after being answered. They checked her blood glucose as a diabetic which was WNL, and they took her to an ED. Diagnosis of TGA and elevated troponin. Amnesia resolved around midnight same day, but was inpatient x2d for troponin levels. Client reports no other symptoms other than redness and soreness at injection site prior to amnesia onset. Client was discharged from hospital after resolution of high troponin, no DC medications or plan for follow-up visits.
Age: 43.0
Sex: F
Vaccine: FLUA4
Symptoms: Product storage error
Clinical narrative: Vaccine storage Temp issue DOH advised to repeat
Age: 68.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: No reaction or injury.
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chest X-ray, Fall, Fatigue, Respiratory tract congestion
Clinical narrative: Patient present to ED after a fall in his bathroom. Had congestion/fatigue for 2 days prior to this. Wife has also been ill.
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Sick relative
Clinical narrative: Patient present to ED after a fall in his bathroom. Had congestion/fatigue for 2 days prior to this. Wife has also been ill.
Age: 70.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough Case
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Breast cancer female, Breast mass
Clinical narrative: Doctor palp breast mass. Patient has breast cancer
Age: 58.0
Sex: F
Vaccine: COVID19-2
Symptoms: Diarrhoea, Fatigue, Headache, Hypophagia, Pyrexia
Clinical narrative: Severe headache beginning in late afternoon on 10/2/23 Severe vomiting  and diarrhea, fever, beginning approx 2am 10/3/22 ending late evening 10/4/22 Severe fatigue beginning late afternoon 10/2/22 through 10/6/22 Unable to eat or drink from 10/3/22-10/4/22
Age: 58.0
Sex: F
Vaccine: COVID19-2
Symptoms: Vomiting
Clinical narrative: Severe headache beginning in late afternoon on 10/2/23 Severe vomiting  and diarrhea, fever, beginning approx 2am 10/3/22 ending late evening 10/4/22 Severe fatigue beginning late afternoon 10/2/22 through 10/6/22 Unable to eat or drink from 10/3/22-10/4/22
Age: 62.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough Case
Age: 1.75
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: Pt. was due for the second dose of the Monovalent Pfizer (6month-4yrs) covid vaccine but was accidentally given the Pfizer Bivalent (6ms-4yrs) vaccine.  Pt. did not  experience an adverse event from the vaccine.
Age: 90.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough Case
Age: 70.0
Sex: F
Vaccine: FLU4
Symptoms: Blood calcium decreased, Blood glucose normal, Blood sodium, Electrocardiogram normal, Full blood count
Clinical narrative: A few hours after patient received vaccine, she experienced muscle aches in her neck and shoulders; nausea and vomiting.  Upper lip swelling.  Patient is treated with diphenhydramine and IV fluids.
Age: 70.0
Sex: F
Vaccine: FLU4
Symptoms: Lip swelling, Metabolic function test, Myalgia, Vomiting
Clinical narrative: A few hours after patient received vaccine, she experienced muscle aches in her neck and shoulders; nausea and vomiting.  Upper lip swelling.  Patient is treated with diphenhydramine and IV fluids.
Age: 62.0
Sex: F
Vaccine: FLUA4, FLUA4
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: None stated.
Age: 62.0
Sex: F
Vaccine: FLUA4, FLUA4
Symptoms: Product storage error
Clinical narrative: None stated.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Arthralgia, COVID-19, Cough
Clinical narrative: I experienced a breakthrough case of COVID-19 with coughing, fever, loss of taste/smell, joint aches, diarrhea, congestion and loss of appetite.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Decreased appetite, Diarrhoea, Pyrexia, Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: I experienced a breakthrough case of COVID-19 with coughing, fever, loss of taste/smell, joint aches, diarrhea, congestion and loss of appetite.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccine breakthrough infection
Clinical narrative: I experienced a breakthrough case of COVID-19 with coughing, fever, loss of taste/smell, joint aches, diarrhea, congestion and loss of appetite.
Age: 0.17
Sex: F
Vaccine: RV5
Symptoms: Product preparation error
Clinical narrative: Only diluent given, RN did not constitute.
Age: 46.0
Sex: F
Vaccine: COVID19-2
Symptoms: Tinnitus
Clinical narrative: I?ve noticed quite pronounced ringing in my ears over the past few months. I went to my doctor?s office to see if something could be done. She asked if I had had a Covid booster within the past six months, which I told her I had. She said others had reported similar ringing following a Covid booster.
Age: 42.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: Pfizer Bivalent dose given for 1st primary dose, instead of the Pfizer monovalent dose.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blindness, Blood test, Echocardiogram, Endocrine test, Eye symptom
Clinical narrative: Woke up on 12/27/2021 with vision loss - went to opthamologist - sent to Emergency Department for MRI - high blood pressure also diagnosed at same time.  Vision loss progressed over 2 weeks - no official diagnosis yet (symptoms that of an eye stoke though).  Currently being medicated for hypertension as well.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Hypertension, Inflammatory marker test, Liver function test, Magnetic resonance imaging, Renal function test
Clinical narrative: Woke up on 12/27/2021 with vision loss - went to opthamologist - sent to Emergency Department for MRI - high blood pressure also diagnosed at same time.  Vision loss progressed over 2 weeks - no official diagnosis yet (symptoms that of an eye stoke though).  Currently being medicated for hypertension as well.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Ultrasound kidney
Clinical narrative: Woke up on 12/27/2021 with vision loss - went to opthamologist - sent to Emergency Department for MRI - high blood pressure also diagnosed at same time.  Vision loss progressed over 2 weeks - no official diagnosis yet (symptoms that of an eye stoke though).  Currently being medicated for hypertension as well.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Neurological symptom, Visual impairment
Clinical narrative: 30 minutes after COVID vaccine, she had left eye visual disturbance and stroke-like symptoms
Age: 8.0
Sex: F
Vaccine: HEPA
Symptoms: Altered state of consciousness, Cognitive disorder, Disorientation, Lip discolouration, Syncope
Clinical narrative: 8-year-old patient was vaccinated with 2nd dose of Hep A at 10:50. Mother stated that she had eaten breakfast prior to appointment. The vaccine was administered and she waited for 15 minutes before leaving. Patient said that she felt fine and did not appear to be in any sign of distress or sign of any adverse reactions. Approximately an hour later patient and her mother walk into office stating that patient had fainted at school and was called by the school nurse. Her mother assumed that we had medical services available and returned to the office. Patient was asked if she knew her name and where she was, to which she responded correctly. However, when asked who her mother was, she appeared disoriented and was not able to vocalize who she was. Patient was given some juice and cookies and appeared to gain more consciousness after. Patient then was able to explain, that as soon as she walked into class she began to see blurry and dark and experienced ringing in her ears. Her teacher assisted her as she fainted and regained consciousness at the nurse's office. As she was recalling what happened, the color returned to her lips and eyes appeared to focus a bit more while making eye contact. Patient and her mother were advised to go to the emergency room.
Age: 8.0
Sex: F
Vaccine: HEPA
Symptoms: Tinnitus, Vision blurred
Clinical narrative: 8-year-old patient was vaccinated with 2nd dose of Hep A at 10:50. Mother stated that she had eaten breakfast prior to appointment. The vaccine was administered and she waited for 15 minutes before leaving. Patient said that she felt fine and did not appear to be in any sign of distress or sign of any adverse reactions. Approximately an hour later patient and her mother walk into office stating that patient had fainted at school and was called by the school nurse. Her mother assumed that we had medical services available and returned to the office. Patient was asked if she knew her name and where she was, to which she responded correctly. However, when asked who her mother was, she appeared disoriented and was not able to vocalize who she was. Patient was given some juice and cookies and appeared to gain more consciousness after. Patient then was able to explain, that as soon as she walked into class she began to see blurry and dark and experienced ringing in her ears. Her teacher assisted her as she fainted and regained consciousness at the nurse's office. As she was recalling what happened, the color returned to her lips and eyes appeared to focus a bit more while making eye contact. Patient and her mother were advised to go to the emergency room.
Age: 42.0
Sex: F
Vaccine: FLUA4, FLUA4
Symptoms: Product storage error
Clinical narrative: vaccine storage temp issue health department advised to repeat
Age: 34.0
Sex: F
Vaccine: HEP, HPV9, TDAP, VARCEL, HEP, HPV9, TDAP, VARCEL
Symptoms: Pregnancy test urine positive, Uterine haemorrhage, Vaginal haemorrhage
Clinical narrative: 1/18/23 Client reports that she is not pregnant and is currently on period. Varicella vaccine (and others as listed above) administered on 1/18/23. UPT obtained on 1/18/23 resulted as positive. Pt. reports last normal menstrual period on 12/9/22. Reports light bleeding/spotting on 1/6/23 and then bleeding became heavier by 1/15/23. MD impression on that day was concern for threatened abortion and plan was to return to clinic on 1/26/23 for repeat UPT. Pt. was seen on 1/26/23 for repeat UPT which resulted positive. Pt. was sent to ED for further evaluation of state of pregnancy.
Age: 34.0
Sex: F
Vaccine: HEP, HPV9, TDAP, VARCEL, HEP, HPV9, TDAP, VARCEL
Symptoms: Exposure during pregnancy, No adverse event, Pregnancy test urine positive
Clinical narrative: 1/18/23 Client reports that she is not pregnant and is currently on period. Varicella vaccine (and others as listed above) administered on 1/18/23. UPT obtained on 1/18/23 resulted as positive. Pt. reports last normal menstrual period on 12/9/22. Reports light bleeding/spotting on 1/6/23 and then bleeding became heavier by 1/15/23. MD impression on that day was concern for threatened abortion and plan was to return to clinic on 1/26/23 for repeat UPT. Pt. was seen on 1/26/23 for repeat UPT which resulted positive. Pt. was sent to ED for further evaluation of state of pregnancy.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Computerised tomogram, Headache, Transient ischaemic attack
Clinical narrative: Continious headaches and 3 mini strokes
Age: 64.0
Sex: M
Vaccine: COVID19-2, FLU4, PNC20, TDAP
Symptoms: Underdose
Clinical narrative: Patient was vaccinated with COVID booster and under-dosed.